Sugi Predict

Sugi Predict / Compounds / SCHEMBL21991353

SCHEMBL21991353

SCHEMBL21991353

CC(C)OC(=O)CC(C)C(C)Oc1ccc(C(=O)Cc2ccc(Cl)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.49
▸ RAB9A P51151 2/20 0.49
▸ L3MBTL1 Q9Y468 2/20 0.49
▸ MAPT P10636 3/20 0.45
▸ KMT2A Q03164 2/20 0.44
▸ POLB P06746 1/20 0.41
▸ KLK7 P49862 3/20 0.40
▸ PPARG P37231 4/20 0.39
▸ PPARA Q07869 4/20 0.39
▸ TSHR P16473 3/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ USP2 O75604 1/20 0.39
▸ ABCB11 O95342 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ ADORA3 P0DMS8 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ ADRB3 P13945 1/20 0.39
▸ HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21991592 0.89 L3MBTL1 (0.50) NPC1RAB9AL3MBTL1MAPTKMT2A
SCHEMBL21992669 0.88 L3MBTL1 (0.51) NPC1RAB9AL3MBTL1MAPTKMT2A
SCHEMBL21991987 0.88 KMT2A (0.45) MAPTKMT2APOLBPPARGPPARA
SCHEMBL21992008 0.87 L3MBTL1 (0.51) NPC1RAB9AL3MBTL1MAPTKMT2A
SCHEMBL21992002 0.87 L3MBTL1 (0.52) NPC1RAB9AL3MBTL1MAPTKMT2A
SCHEMBL21991344 0.87 KMT2A (0.52) L3MBTL1MAPTKMT2APOLBPPARG
SCHEMBL21991598 0.84 KMT2A (0.42) MAPTKMT2APPARGPPARATSHR
SCHEMBL21991608 0.83 MAOB (0.51) NPC1RAB9AMAPTKMT2APOLB
SCHEMBL21991842 0.83 L3MBTL1 (0.51) NPC1RAB9AL3MBTL1MAPTKMT2A
SCHEMBL24805058 0.81 L3MBTL1 (0.54) NPC1RAB9AL3MBTL1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220409566-A1 CCL5 Inhibitors LAPKO INC, dba AFECTA PHARMACEUTICALS 2022-12-29 — — US disclosed
US-20220142961-A1 CCL5 Inhibitors LAPKO INC, dba AFECTA PHARMACEUTICALS 2022-05-12 — — US disclosed
US-11318111-B2 CCL5 inhibitors LAPKO INC (US) 2022-05-03 — — US disclosed
US-20210196665-A1 CCL5 Inhibitors AFECTA PHARMACEUTICALS, INC. (US) 2021-07-01 — — US disclosed
US-10940132-B2 CCL5 inhibitors AFECTA PHARMACEUTICALS, INC. (US) 2021-03-09 — — US disclosed
US-20200138766-A1 CCL5 INHIBITORS LAPKO INC. DBA AFECTA PHARMACEUTICALS 2020-05-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220142961-A1 CCL5 Inhibitors CCL5, CCL11, CCR5 NPC1 233/4885RAB9A 1547/4885L3MBTL1 1170/4885
US-20200138766-A1 CCL5 INHIBITORS CCL5, CCL11, CCR5 NPC1 233/4885RAB9A 1547/4885L3MBTL1 1170/4885
US-20210196665-A1 CCL5 Inhibitors CCL5, CCL11, CCR5 NPC1 233/4885RAB9A 1547/4885L3MBTL1 1170/4885
US-10940132-B2 CCL5 inhibitors CCL5, CCL11, CCR5 NPC1 233/4885RAB9A 1547/4885L3MBTL1 1170/4885
US-11318111-B2 CCL5 inhibitors CCL5, CCL11, CCR5 NPC1 233/4885RAB9A 1547/4885L3MBTL1 1170/4885
US-20220409566-A1 CCL5 Inhibitors CCL5, CCL11, CCR5 NPC1 233/4885RAB9A 1547/4885L3MBTL1 1170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.